Peptide library / Hormones & metabolism / Dasiglucagon
Dasiglucagon
A stable glucagon analog that does not need to be mixed before use.
Effects studied or claimed
What it is used or promoted for, and where each effect has actually been seen
- Severe hypoglycemia rescueFDA approved
- Congenital hyperinsulinism, studiedLarge trials
How it is thought to work
Dasiglucagon has amino acid changes that make it resistant to clumping in liquid, so it is ready to inject straight from a pen.
What the evidence shows
Trials in people with type 1 diabetes showed rapid recovery of blood glucose, similar to glucagon.
Safety and unknowns
Nausea, vomiting and injection site reactions were most common.
Regulatory status
FDA-approved as Zegalogue in 2021.
Regulatory status changes quickly. This entry was last reviewed on 27 October 2026. Confirm current status with the FDA before relying on it.
More in Hormones & metabolism
Degarelix
FDA-approvedA GnRH antagonist for advanced prostate cancer that lowers testosterone without an initial surge.
Desmopressin
FDA-approvedA synthetic vasopressin analog that reduces urine production.
Cosyntropin
FDA-approvedThe first 24 amino acids of ACTH, used as a test for adrenal insufficiency.
General information, not medical advice. Do not buy or inject unregulated peptides.